427 related articles for article (PubMed ID: 29678143)
1. Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population.
Podralska M; Ziółkowska-Suchanek I; Żurawek M; Dzikiewicz-Krawczyk A; Słomski R; Nowak J; Stembalska A; Pesz K; Mosor M
BMC Cancer; 2018 Apr; 18(1):452. PubMed ID: 29678143
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged Lu J; Wei Q; Bondy ML; Brewster AM; Bevers TB; Yu TK; Buchholz TA; Meric-Bernstam F; Hunt KK; Singletary SE; Wang LE
Breast Cancer Res Treat; 2008 Jul; 110(2):357-66. PubMed ID: 17851762
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
[TBL] [Abstract][Full Text] [Related]
4. Sex- and subtype-specific analysis of H2AFX polymorphisms in non-Hodgkin lymphoma.
Bretherick KL; Schuetz JM; Morton LM; Purdue MP; Conde L; Gallagher RP; Connors JM; Gascoyne RD; Berry BR; Armstrong B; Kricker A; Vajdic CM; Grulich A; Hjalgrim H; Smedby KE; Skibola CF; Rothman N; Spinelli JJ; Brooks-Wilson AR
PLoS One; 2013; 8(9):e74619. PubMed ID: 24069324
[TBL] [Abstract][Full Text] [Related]
5. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study.
Damiola F; Pertesi M; Oliver J; Le Calvez-Kelm F; Voegele C; Young EL; Robinot N; Forey N; Durand G; Vallée MP; Tao K; Roane TC; Williams GJ; Hopper JL; Southey MC; Andrulis IL; John EM; Goldgar DE; Lesueur F; Tavtigian SV
Breast Cancer Res; 2014 Jun; 16(3):R58. PubMed ID: 24894818
[TBL] [Abstract][Full Text] [Related]
6. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of genetic polymorphisms in the H2AFX distal promoter.
Bretherick KL; Leach S; Brooks-Wilson AR
Mutat Res; 2014; 766-767():37-43. PubMed ID: 25847270
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms of ataxia telangiectasia mutated and the risk of papillary thyroid carcinoma.
Song CM; Kwon TK; Park BL; Ji YB; Tae K
Environ Mol Mutagen; 2015 Jan; 56(1):70-6. PubMed ID: 25196645
[TBL] [Abstract][Full Text] [Related]
9. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer.
Kim H; Cho DY; Choi DH; Oh M; Shin I; Park W; Huh SJ; Nam SJ; Lee JE; Kim SW
Breast Cancer Res Treat; 2017 Jan; 161(1):95-102. PubMed ID: 27783279
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk associated with genes encoding DNA repair MRN complex: a study from Punjab, Pakistan.
Khan RT; Siddique A; Shahid N; Khokher S; Fatima W
Breast Cancer; 2018 May; 25(3):350-355. PubMed ID: 29368209
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes.
Allen-Brady K; Camp NJ
BMC Cancer; 2005 Aug; 5():99. PubMed ID: 16091150
[TBL] [Abstract][Full Text] [Related]
12. Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.
Kim KY; Han W; Noh DY; Kang D; Kwack K
Gene; 2013 Dec; 532(2):192-6. PubMed ID: 24076439
[TBL] [Abstract][Full Text] [Related]
13. Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
Ramezani S; Sharafshah A; Mirzanejad L; Hadavi M
Gene; 2019 Sep; 712():143954. PubMed ID: 31288058
[TBL] [Abstract][Full Text] [Related]
14. Possible association between genetic variants in the H2AFX promoter region and risk of adult glioma in a Chinese Han population.
Fan W; Zhou K; Zhao Y; Wu W; Chen H; Jin L; Chen G; Shi J; Wei Q; Zhang T; Du G; Mao Y; Lu D; Zhou L
J Neurooncol; 2011 Nov; 105(2):211-8. PubMed ID: 21512825
[TBL] [Abstract][Full Text] [Related]
15. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
[TBL] [Abstract][Full Text] [Related]
16. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
17. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
18. Association between single nucleotide polymorphisms of DNA damage response pathway genes and increased risk in breast cancer.
Mehmood A; Kayani MA; Ahmed MW; Nisar A; Mahjabeen I
Future Oncol; 2020 Sep; 16(26):1977-1995. PubMed ID: 32597209
[No Abstract] [Full Text] [Related]
19. Correlation between LSP1 polymorphisms and the susceptibility to breast cancer.
Chen H; Qi X; Qiu P; Zhao J
Int J Clin Exp Pathol; 2015; 8(5):5798-802. PubMed ID: 26191300
[TBL] [Abstract][Full Text] [Related]
20. Three new cases of ataxia-telangiectasia-like disorder: No impairment of the ATM pathway, but S-phase checkpoint defect.
Fiévet A; Bellanger D; Valence S; Mobuchon L; Afenjar A; Giuliano F; Dubois d'Enghien C; Parfait B; Pedespan JM; Auger N; Rieunier G; Collet A; Burglen L; Stoppa-Lyonnet D; Stern MH
Hum Mutat; 2019 Oct; 40(10):1690-1699. PubMed ID: 31033087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
